Newport Premium

The Power of Generics Insights

 

Your challenges and opportunities

  • Identifying candidate products meeting specific criteria
  • Choosing the best new market to pursue
  • Identifying new partners to manage costs and diversify the portfolio
  • Securing the most reliable & cost effective API supplier
  • Identifying opportunities to grow either by organic growth, internal or external investment or M&A
Biosimilar thumbnail

MENA and Latin America: Attractive markets for opportunities in innovation and generics

The pharmaceutical markets in Middle East & North Africa (MENA) and Latin America offer a promising opportunity to pharmaceutical companies, in both the innovative and generics sectors.

Learn more about the strategies employed by successful drugmakers in the MENA region with deep analysis on 12 markets in Middle East and Africa and a look at the LATAM market with a special focus on Brazil and Argentina.

Newport Premium

from Clarivate Analytics

Trusted by 80% of the world’s Top 50 generic and API manufacturers, Newport Premium is the most advanced product targeting, global business development and API intelligence system from the industry.

12,500+

APIs

140,000+

Finished Dose Forms

66,000+

Manufacturers & Marketers


Newport Premium enables companies of all sizes, business models, strategies and geographic reach to quickly grow their product portfolios, find exclusive API suppliers, penetrate new markets, identify partners and monitor their competition.

Learn more